| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/11/2011 | WO2011097384A2 Tumor targeted delivery of immunomodulators by nanoplymers |
| 08/11/2011 | WO2011097327A2 Compositions and methods of modulating receptor protein tyrosine phosphatases |
| 08/11/2011 | WO2011097268A1 Method for sensitizing cells to cancer therapy |
| 08/11/2011 | WO2011097221A2 Methods of promoting tissue growth and tissue regeneration |
| 08/11/2011 | WO2011097216A1 Vaccine and methods of use against strongyloides stercoralis infection |
| 08/11/2011 | WO2011097166A2 Combination therapy for treating cancer comprising an igf-1r inhibitor and an hdac inhibitor |
| 08/11/2011 | WO2011096535A1 Pharmaceutical agent for treatment and/or prevention of cancer |
| 08/11/2011 | WO2011096534A1 Pharmaceutical composition for treatment and/or prevention of cancer |
| 08/11/2011 | WO2011096533A1 Pharmaceutical composition for treatment and/or prevention of cancer |
| 08/11/2011 | WO2011096528A1 Pharmaceutical composition for treatment and/or prevention of cancer |
| 08/11/2011 | WO2011096519A1 Medicinal composition for treating and/or preventing cancer |
| 08/11/2011 | WO2011096517A1 Pharmaceutical composition for treatment and/or prevention of cancer |
| 08/11/2011 | WO2011096438A1 Method and pharmaceutical composition for treatment of intestinal disease |
| 08/11/2011 | WO2011095760A1 Bunyavirus vaccine |
| 08/11/2011 | WO2011095649A1 Use of flagellins from the genus marinobacter as vaccination adjuvants |
| 08/11/2011 | WO2011095596A1 Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells |
| 08/11/2011 | WO2011095543A1 Immunoglobulin preparation |
| 08/11/2011 | WO2011095498A1 A monoclonal antibody to cd44 for use in the treatment of head and neck squamous cell carcinoma |
| 08/11/2011 | WO2011095402A1 Immunization compositions and methods |
| 08/11/2011 | WO2011073796A3 Codon-optimzed hepatitis b virus core antigen (hbcag) |
| 08/11/2011 | WO2011073629A3 Cancer diagnosis and treatment |
| 08/11/2011 | WO2011054996A3 Vaccines for the treatment of neoplasias from viral capsids of birnavirus containing antigens of the human papillomavirus |
| 08/11/2011 | WO2011046757A9 Accelerating thrombus resolution through augmentation of p53 activity |
| 08/11/2011 | WO2011031063A3 Composition for preventing or treating metabolic disorders, containing the anti-4-1bb antibody |
| 08/11/2011 | WO2010042543A3 Use of inhibitors of toll-like receptors in the prevention and treatment of hypercholesterolemia and hyperlipidemia and diseases related thereto |
| 08/11/2011 | WO2006045308A8 Chlamydia trachomatis antigens for vaccine and diagnostic use |
| 08/11/2011 | US20110196285 Hollow Mesoporous Silica Sphere Coated with Gold and Preparation Method Thereof and Use in Cancer Therapy |
| 08/11/2011 | US20110196128 Murine zcytor17 ligand polynucleotides |
| 08/11/2011 | US20110195901 Artery- and vein-specific proteins and uses therefor |
| 08/11/2011 | US20110195456 Methods and compositions for the production of monoclonal antibodies |
| 08/11/2011 | US20110195124 Phase-transition polymeric microneedles |
| 08/11/2011 | US20110195113 Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity |
| 08/11/2011 | US20110195110 Urea compounds useful in the treatment of cancer |
| 08/11/2011 | US20110195097 Composition and dosage form comprising a particle formulation and suspending vehicle |
| 08/11/2011 | US20110195093 Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers |
| 08/11/2011 | US20110195092 Live attenuated aldolase-negative bacterial vaccine |
| 08/11/2011 | US20110195091 Avian Influenza Virus Antigen, and Booster Immunization Method for Avian Influenza Vaccine in Combination with Mucosal Adjuvant Which is Effective Through Oral Administration |
| 08/11/2011 | US20110195090 Method of making a vaccine |
| 08/11/2011 | US20110195089 Compositions, methods, and kits for enhancing the immunogenicity of pathogenic antigens |
| 08/11/2011 | US20110195088 Porcine Reproductive and Respiratory Syndrome Isolates and Methods of Use |
| 08/11/2011 | US20110195087 Combination vaccine with whole cell pertussis |
| 08/11/2011 | US20110195086 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition |
| 08/11/2011 | US20110195084 Anti-HIV Vaccine Constructed Based on Amino Acid Mutations in Attenuated Live EIAV Vaccine |
| 08/11/2011 | US20110195083 Cyclic v3 peptides for anti hiv-1 vaccine |
| 08/11/2011 | US20110195082 Multimeric Complexes of Antigens and an Adjuvant |
| 08/11/2011 | US20110195081 Foxm1 peptide and medicinal agent comprising the same |
| 08/11/2011 | US20110195080 Compositions and Methods for Enhanced Somatostatin Immunogenicity in the Treatment of Growth Hormone and Insulin-Like Growth Factor One Deficiency |
| 08/11/2011 | US20110195079 Immunization protocol for directed expansion and maturation |
| 08/11/2011 | US20110195078 Tat-based immunomodulatory compositions and methods for their discovery and use |
| 08/11/2011 | US20110195077 Methods and compositions using fgf23 fusion ppolypeptides |
| 08/11/2011 | US20110195076 Therapeutic agent |
| 08/11/2011 | US20110195075 Use of a pneumococcal p4 peptide for enhancing opsonophagocytosis in response to a pathogen |
| 08/11/2011 | US20110195074 Ephrin Type-A Receptor 7 Protein |
| 08/11/2011 | US20110195073 Compositions and methods for stimulating an immune response |
| 08/11/2011 | US20110195072 Non-neuroendocrine cancer therapy |
| 08/11/2011 | US20110195071 Therapy-enhancing glucan |
| 08/11/2011 | US20110195070 Detection of granulosa-cell tumors |
| 08/11/2011 | US20110195069 Inhibitors of complement activation |
| 08/11/2011 | US20110195068 Pd-1 antagonists and methods of use thereof |
| 08/11/2011 | US20110195067 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCy RECEPTORS |
| 08/11/2011 | US20110195066 Quinoline inhibitors of tyrosine kinase |
| 08/11/2011 | US20110195065 Compositions and Methods for Diagnosing and Treating Cancer |
| 08/11/2011 | US20110195064 Survival predictor for diffuse large b cell lymphoma |
| 08/11/2011 | US20110195063 Methods of Treating Ankylosing Spondylitis Using Anti-TNF Antibodies and Peptides of Human Tumor Necrosis Factor |
| 08/11/2011 | US20110195062 Mammalian Cytokines; Related Reagents and Methods |
| 08/11/2011 | US20110195049 Compositions and methods for treating multiple sclerosis |
| 08/11/2011 | US20110195048 Regulation of lymphocytes and uses therefor |
| 08/11/2011 | US20110195045 Methods, agents and peptides for inducing an immune response to matrix metalloproteinase-2 expressing tumors |
| 08/11/2011 | US20110195043 Dimeric Smac Mimetics |
| 08/11/2011 | US20110195031 Methods for the use of progestogen as a glucocorticoid sensitizer |
| 08/11/2011 | US20110195027 Cd9-specific human antibodies |
| 08/11/2011 | US20110195026 Protein |
| 08/11/2011 | US20110195023 Internalizing Anti-CD74 Antibodies and Methods of Use |
| 08/11/2011 | US20110195022 Cd20 antibodies and uses thereof |
| 08/11/2011 | US20110195021 Cd20 antibodies and uses thereof |
| 08/11/2011 | US20110195020 Methods and Compositions for Generating Bioactive Assemblies of Increased Complexity and Uses |
| 08/11/2011 | US20110195019 Nucleic acids and corresponding proteins entitled 251p5g2 useful in treatment and detection of cancer |
| 08/11/2011 | CA2791975A1 Icos critically regulates the expansion and function of inflammatory human th17 cells |
| 08/11/2011 | CA2789230A1 Antibody drug conjugates (adc) that bind to 161p2f10b proteins |
| 08/11/2011 | CA2789022A1 Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use therefor |
| 08/11/2011 | CA2788902A1 Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same |
| 08/11/2011 | CA2788863A1 Immunoglobulin preparation |
| 08/11/2011 | CA2788720A1 Medicament for treating and/or preventing cancer |
| 08/11/2011 | CA2788718A1 Pharmaceutical composition for treating and/or preventing cancer |
| 08/11/2011 | CA2788716A1 Pharmaceutical composition for treating and/or preventing cancer |
| 08/11/2011 | CA2788715A1 Pharmaceutical composition for treating and/or preventing cancer |
| 08/11/2011 | CA2788640A1 Method for sensitizing cells to cancer therapy |
| 08/11/2011 | CA2788547A1 Pharmaceutical composition for treating and/or preventing cancer |
| 08/11/2011 | CA2788545A1 Pharmaceutical composition for treating and/or preventing cancer |
| 08/11/2011 | CA2786337A1 A monoclonal antibody to cd44 for use in the treatment of head and neck squamous cell carcinoma |
| 08/10/2011 | EP2354230A1 Neisseria meningitidis surface protein |
| 08/10/2011 | EP2354221A2 Porcine circovirus type 2 and use thereof |
| 08/10/2011 | EP2354162A1 Anti-CD3 antibody formulations |
| 08/10/2011 | EP2354161A1 Anti-nr10 antibody, and use thereof |
| 08/10/2011 | EP2354160A1 Engineered anti-IL-23-antibodies |
| 08/10/2011 | EP2354154A1 Recombinant methylated mycobacterial heparin-binding hemagglutinin antigen |
| 08/10/2011 | EP2354153A2 Stable peptide mimetic of HIV gp41 fusion intermediate |
| 08/10/2011 | EP2354149A1 Molecules with extended half-lives, compositions and uses thereof |
| 08/10/2011 | EP2353611A2 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| 08/10/2011 | EP2353610A1 Recombinant inactivated viral vector vaccine |